Cargando…
Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in “Treating” Aortic Valve Calcification
The treatment of patients with aortic valve calcification (AVC) and calcific aortic valve stenosis (CAVS) remains challenging as, until today, all non-invasive interventions have proven fruitless in preventing the disease’s onset and progression. Despite the similarities in the pathogenesis of AVC a...
Autores principales: | Tsamoulis, Donatos, Siountri, Iliana, Rallidis, Loukianos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056331/ https://www.ncbi.nlm.nih.gov/pubmed/36975859 http://dx.doi.org/10.3390/jcdd10030096 |
Ejemplares similares
-
Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019) -
Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023) -
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020) -
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
por: Zheng, Kang H., et al.
Publicado: (2019) -
Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease
por: Mathieu, Patrick, et al.
Publicado: (2019)